These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9585608)

  • 1. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.
    Huusko P; Pääkkönen K; Launonen V; Pöyhönen M; Blanco G; Kauppila A; Puistola U; Kiviniemi H; Kujala M; Leisti J; Winqvist R
    Am J Hum Genet; 1998 Jun; 62(6):1544-8. PubMed ID: 9585608
    [No Abstract]   [Full Text] [Related]  

  • 2. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
    Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
    Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
    Sarantaus L; Vahteristo P; Bloom E; Tamminen A; Unkila-Kallio L; Butzow R; Nevanlinna H
    Eur J Hum Genet; 2001 Jun; 9(6):424-30. PubMed ID: 11436123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.
    de los Rios P; Jack E; Kuperstein G; Lynch H; Lubinski J; Narod SA
    Am J Hum Genet; 2001 Feb; 68(2):546. PubMed ID: 11170903
    [No Abstract]   [Full Text] [Related]  

  • 7. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
    Tonin PN; Mes-Masson AM; Futreal PA; Morgan K; Mahon M; Foulkes WD; Cole DE; Provencher D; Ghadirian P; Narod SA
    Am J Hum Genet; 1998 Nov; 63(5):1341-51. PubMed ID: 9792861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.
    Lahti-Domenici J; Rapakko K; Pääkkönen K; Allinen M; Nevanlinna H; Kujala M; Huusko P; Winqvist R
    Cancer Genet Cytogenet; 2001 Sep; 129(2):120-3. PubMed ID: 11566341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.
    Tonin PN; Perret C; Lambert JA; Paradis AJ; Kantemiroff T; Benoît MH; Martin G; Foulkes WD; Ghadirian P
    Int J Cancer; 2001 May; 95(3):189-93. PubMed ID: 11307153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.
    Papp J; Raicevic L; Milasin J; Dimitrijevic B; Radulovic S; Olah E
    Oncol Rep; 1999; 6(6):1435-8. PubMed ID: 10523726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D; Kaduri L; Lerer I; Weinberg N; Amir G; Sagi M; Zlotogora J; Heching N; Peretz T
    Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
    Sarantaus L; Auranen A; Nevanlinna H
    Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 18. A low proportion of BRCA2 mutations in Finnish breast cancer families.
    Vehmanen P; Friedman LS; Eerola H; Sarantaus L; Pyrhönen S; Ponder BA; Muhonen T; Nevanlinna H
    Am J Hum Genet; 1997 May; 60(5):1050-8. PubMed ID: 9150152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
    Tonin P; Weber B; Offit K; Couch F; Rebbeck TR; Neuhausen S; Godwin AK; Daly M; Wagner-Costalos J; Berman D; Grana G; Fox E; Kane MF; Kolodner RD; Krainer M; Haber DA; Struewing JP; Warner E; Rosen B; Lerman C; Peshkin B; Norton L; Serova O; Foulkes WD; Garber JE
    Nat Med; 1996 Nov; 2(11):1179-83. PubMed ID: 8898735
    [No Abstract]   [Full Text] [Related]  

  • 20. Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
    Friedman E; Bar-Sade Bruchim R; Kruglikova A; Risel S; Levy-Lahad E; Halle D; Bar-On E; Gershoni-Baruch R; Dagan E; Kepten I; Peretz T; Lerer I; Wienberg N; Shushan A; Abeliovich AD
    Am J Hum Genet; 1998 Oct; 63(4):1224-7. PubMed ID: 9758598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.